The Daughter’s Return
By The Economist,
The Economist
| 12. 31. 2011
A glimmer of hope in the sad tale of sex-selective abortion in India
THE march of sex-selective abortion in Asia seems relentless. Not every society adopts the practice, but those that do—and they include the two largest countries on earth—have seen it spread through every social group, unhampered by growing wealth. Indeed, middle-income couples seem more willing and better able to manipulate the sex of their children than are the poor. And they are more likely to want smaller families, increasing the premium on sons in countries where males are seen as more valuable.
As a result, richer areas have more sex selection than poorer ones and sex selection tends to rise as countries get richer. In China the sex ratio at birth is much more distorted in rich Shanghai and Guangzhou than in poor Tibet. From 2001-11, India’s GDP more than doubled and the census of 2011 found only 914 girls aged 0-6 for every 1,000 boys, worse even than the abysmal tally in 2001, when there were 927 girls per 1,000 boys. (India counts the sex ratio differently...
Related Articles
By Samuelle Fajutrao Falk , The Conversation | 06.26.2026
When my colleagues and I asked autistic people and parents of autistic children in Sweden how they feel about genetic research in autism, one response stood out: “I hope genetic research finds new ways to help us, not erase us.”...
By Rebecca Simkin, BioNews | 06.29.2026
The US Food and Drug Administration (FDA) is allowing biotech company Regenxbio to reapply for licensing of a gene therapy for Hunter syndrome, in a reversal of its previous decision. Hunter syndrome, or mucopolysaccharidosis type II (MPS II), is a...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Paul Knoepfler, Stat | 06.24.2026
What if you could precisely change the genome of a pre-implantation human embryo and then safely use that embryo to try to generate a healthier person? It’s a wild idea, but one that technology over the past decade has steadily...